ArticleDiagnostic pathology2024

Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer.

Feng Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.